Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Porton Biologics is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the cell and gene therapy (CGT) sector. Headquartered in Suzhou, China, the company offers a comprehensive service platform encompassing plasmid DNA, viral vectors, cell therapy, and mRNA technologies. Their capabilities range from process development and analytical testing to clinical and commercial-scale GMP manufacturing. As a subsidiary of Porton Pharma Solutions, Porton Biologics serves a global clientele, helping to accelerate the transition of advanced therapies from the lab to the clinic. The company operates advanced facilities that comply with international regulatory standards, including those of the FDA, EMA, and NMPA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Porton Biologics.